Semnur Pharmaceuticals, Inc. (SMNR) Operating cash flow 2022–2025
Semnur Pharmaceuticals, Inc. (SMNR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2022: -$426,095 → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | -20.0% |
| FY2024 | -$4.9M | -672.9% |
| FY2023 | -$632,783 | -48.5% |
| FY2022 | -$426,095 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNR financial trends
SMNR RevenueSMNR Net incomeSMNR Net marginSMNR Gross profitSMNR Gross marginSMNR Operating incomeSMNR Operating marginSMNR Free cash flowSMNR Capital expendituresSMNR Return on equitySMNR Stock buybacksSMNR Dividends paidSMNR Total assetsSMNR Total liabilitiesSMNR Shareholders’ equitySMNR overview →